Quantifying in vivo collagen reorganization during immunotherapy in murine melanoma with second harmonic generation imaging
Abstract
SignificanceIncreased collagen linearization and deposition during tumorigenesis can impede immune cell infiltration and lead to tumor metastasis. Although melanoma is well studied in immunotherapy research, studies that quantify collagen changes during melanoma progression and treatment are lacking. AimImage in vivo collagen in preclinical melanoma models during immunotherapy and quantify the collagen phenotype in treated and control mice. ApproachSecond harmonic generation imaging of collagen was performed in mouse melanoma tumors in vivo over a treatment time-course. Animals were treated with a curative radiation and immunotherapy combination. Collagen morphology was quantified over time at an image and single fiber level using CurveAlign and CT-FIRE software. ResultsIn immunotherapy-treated mice, collagen reorganized toward a healthy phenotype, including shorter, wider, curlier collagen fibers, with modestly higher collagen density. Temporally, collagen fiber straightness and length changed late in treatment (Day 9 and 12) while width and density changed early (Day 6) compared to control mice. Single fiber level collagen analysis was most sensitive to the changes between treatment groups compared to image level analysis. ConclusionsQuantitative second harmonic generation imaging can provide insight into collagen dynamics in vivo during immunotherapy, with key implications in improving immunotherapy response in melanoma and other cancers.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Collagen mineralization decreases NK cell-mediated cytotoxicity of breast cancer cells via increased glycocalyx thickness
Sangwoo Park, Siyoung Choi, … Matthew J. Paszek·Advanced MaterialsPeer-reviewed·Jan 27, 2024
- Immune cell senescence drives responsiveness to immunotherapy in melanoma
Pavlos Pantelis, Dimitrios Christos Tremoulis, … Vassilis G. Gorgoulis·Molecular CancerPeer-reviewed·Dec 10, 2025
- Collagen remodeling promotes a GPCR-mediated mechanosensory immune checkpoint in ADGRG1+ CD8+ T cells and serves as a spatial biomarker of response to immunotherapy
Sonal Srivastava, John Joseph Powers, … Antonio L. Amelio·bioRxiv·Dec 22, 2025
- Collagen type I promotes pancreatic tumor growth and limits immune cell infiltration
Marie‐Louise Thorseth, Astrid Zedlitz Johansen, … Daniel Hargbøll Madsen·bioRxiv·Jan 10, 2026
- Tumor-localized interleukin-2 and interleukin-12 combine with radiation therapy to safely potentiate regression of advanced malignant melanoma in pet dogs
Jordan A. Stinson, Matheus Moreno P. Barbosa, … Timothy M. Fan·Clinical Cancer ResearchPeer-reviewed·Jul 9, 2024
- CREB5 promotes immunotherapy resistance via tumor-intrinsic collagenmatrix deposition
Payal Tiwari, Kayla J. Colvin, … Robert T. Manguso·bioRxiv·Apr 22, 2025